Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Family FINGER: lifestyle support for older spousal caregivers

Official title: Family FINGER: a Pilot Randomised Controlled Trial of Healthy Lifestyle Intervention Versus Standard Care Among Older Caregivers

Run by University of Eastern Finland · NCT07627386 · Data updated 2026-11-12

This study tests a multidomain lifestyle program to improve positive mental health in 65+ spousal caregivers living with a partner who has cognitive impairment.

More Mental Health trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Eastern Finland
Academic / other
Locations1 site (Kuopio)
StatusRecruiting
StartedJune 22, 2026
Main results expectedApril 30, 2028
Study endsApril 30, 2028
Registry record updatedJuly 8, 2026
Trial IDNCT07627386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are caregivers aged 65+ who live with and care for a spouse with cognitive impairment in Northern Savo, Finland, and have at least one modifiable health risk factor.

Probably not a fit

Caregivers without modifiable risk factors, or those requiring specialized health or social care services beyond the intervention, may see limited benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel-group pilot trial conducted in Northern Savo, Finland, enrolling up to 100 older spousal caregivers living with a cognitively impaired partner. Participants are randomly assigned to the Family FINGER lifestyle intervention or standard care, with the primary outcome of positive mental health measured at 12 months. The intervention adapts the Finnish FINGER model to address caregivers’ needs, focusing on lifestyle, diet, physical activity, cognition, and social engagement, along with stress and quality of life assessments. Secondary outcomes include dementia risk, cognitive function, and broader health and lifestyle factors. Safety and feasibility are also monitored as part of the pilot.

Why it matters

Potential benefit: If successful, the intervention could improve caregivers’ mental well-being and potentially reduce dementia risk factors.

How similar studies have gone: Previous multi-domain lifestyle interventions like FINGER showed cognitive and health benefits in similar populations, supporting potential success for Family FINGER.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 65 and older.
* Caregiver for a spouse with cognitive impairment.
* Live in the same household with the care recipient.
* The presence of modifiable risk factors for health: at least one self-reported lifestyle-related risk factor, or self-reported CAIDE dementia risk scores of 6 or higher, or a self-reported burdensome caregiving situation.

Exclusion Criteria:

* A medication for Alzheimer's disease or diagnosis of dementia or suspected dementia (such as referral to or ongoing assessment process at memory clinic, or MoCa \< 18 points).
* Any health condition affecting safe engagement in the intervention, or the caregiving situation is such that specialised social or health care services are needed before safe engagement in the intervention can be ensured, according to clinical judgement.

Where it's running

  • Department of Nursing Science
    Kuopio, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.